Fast Radius (FSRDQ) 10-Q 22 Nov 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Nov. 22, 2021
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Entity Registrant Name	ECP Environmental Growth Opportunities Corp.
Entity Central Index Key	0001832351
Entity Tax Identification Number	85-3692788
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity File Number	001-40032
Entity Shell Company	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Small Business	true
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	40 Beechwood Road
Entity Address, City or Town	Summit
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07901
City Area Code	973
Local Phone Number	671-6100
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	ENNV
Security Exchange Name	NASDAQ
Units
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-quarter of one warrant
Trading Symbol	ENNVU
Security Exchange Name	NASDAQ
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	ENNVW
Security Exchange Name	NASDAQ
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		34,500,000
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		8,625,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
ASSETS
Cash	$ 133,154	$ 24,980
Prepaid expenses	725,543
Total current assets	858,697	24,980
Deferred offering costs associated with public offering		369,379
Marketable securities held in Trust Account	345,026,384
Other assets	260,400
Total assets	346,145,481	394,359
Current liabilities:
Accounts payable	195,396	100,187
Due to related party	399,702
Accrued expenses	1,355,257	269,192
Franchise tax payable	119,400
Total current liabilities	2,069,755	369,379
Warrant liabilities	12,312,430
Forward purchase agreement	100,000
Deferred underwriting commission	12,075,000
Total liabilities	26,557,185	369,379
Commitments and Contingencies (Note 6)
Stockholders' (Deficit) Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	1,362,100	24,137
Accumulated deficit	(26,774,667)	(20)
Total stockholders' (deficit) equity	(25,411,704)	24,980
Total liabilities and stockholders' (deficit) equity	346,145,481	394,359
Class A Common Stock
Current liabilities:
Class A common stock, $0.0001 par value, subject to possible redemption; 34,500,000 shares at $10.00 redemption value	345,000,000
Class B Common Stock
Stockholders' (Deficit) Equity:
Common Stock, Value	$ 863	$ 863

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical)	Sep. 30, 2021$ / sharesshares
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A Common Stock
Common stock subject to possible redemption	34,500,000
Common stock subject to possible redemption, Par value | $ / shares	$ 0.0001
Common stock subject to possible redemption, value | $ / shares	10
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	100,000,000
Common stock, shares issued	0
Common stock, shares outstanding	0
Class B Common Stock
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares authorized	10,000,000
Common stock, shares issued	8,625,000
Common stock, shares outstanding	8,625,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
General and administrative	$ 1,484,290	$ 2,837,151
Franchise tax expense	50,000	119,400
Loss from operations	(1,534,290)	(2,956,551)
Other Income (Expense)
Offering costs allocated to derivative liabilities		(750,743)
Offering costs on Founder Shares issued to related party		(1,249,759)
Interest and dividends earned on marketable securities held in Trust Account	4,440	26,384
Change in fair value of warrant liabilities	8,535,903	9,926,785
Change in fair value of forward purchase agreement	1,648,750	1,408,461
Net income	8,654,803	6,404,577
Class A Redeemable Common Stock
Other Income (Expense)
Net income	$ 6,923,842	$ 4,970,883
Weighted average shares outstanding, basic and diluted	34,500,000	29,318,681
Basic and diluted net earnings per share	$ 0.20	$ 0.17
Class B Non-Redeemable Common Stock
Other Income (Expense)
Net income	$ 1,730,961	$ 1,433,694
Weighted average shares outstanding, basic and diluted	8,625,000	8,456,044
Basic and diluted net earnings per share	$ 0.20	$ 0.17

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)	Total	Common StockClass B Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 24,980	$ 863	$ 24,137	$ (20)
Beginning balance, Shares at Dec. 31, 2020		8,625,000
Excess cash received over fair value of Private Placement Warrants	41,360		41,360
Accretion of Class A Common Stock to redemption value	(33,244,721)		(65,497)	(33,179,224)
Net income (loss)	8,028,639			8,028,639
Ending balance at Mar. 31, 2021	(25,149,742)	$ 863		(25,150,605)
Ending balance, Shares at Mar. 31, 2021		8,625,000
Beginning balance at Dec. 31, 2020	24,980	$ 863	24,137	(20)
Beginning balance, Shares at Dec. 31, 2020		8,625,000
Share-based compensation, cash offering costs, and offering costs on Founder Shares issued to related party and directors	2,647,500
Accretion of Class A Common Stock to redemption value	(34,530,121)
Ending balance at Jun. 30, 2021	(34,066,507)	$ 863	1,362,100	(35,429,470)
Ending balance, Shares at Jun. 30, 2021		8,625,000
Beginning balance at Dec. 31, 2020	24,980	$ 863	24,137	(20)
Beginning balance, Shares at Dec. 31, 2020		8,625,000
Accretion of Class A Common Stock to redemption value	(34,530,121)
Net income (loss)	6,404,577
Ending balance at Sep. 30, 2021	(25,411,704)	$ 863	1,362,100	(26,774,667)
Ending balance, Shares at Sep. 30, 2021		8,625,000
Beginning balance at Mar. 31, 2021	(25,149,742)	$ 863		(25,150,605)
Beginning balance, Shares at Mar. 31, 2021		8,625,000
Share-based compensation, cash offering costs, and offering costs on Founder Shares issued to related party and directors	2,647,500		2,647,500
Accretion of Class A Common Stock to redemption value	(1,285,400)		(1,285,400)
Net income (loss)	(10,278,865)			(10,278,865)
Ending balance at Jun. 30, 2021	(34,066,507)	$ 863	1,362,100	(35,429,470)
Ending balance, Shares at Jun. 30, 2021		8,625,000
Net income (loss)	8,654,803			8,654,803
Ending balance at Sep. 30, 2021	$ (25,411,704)	$ 863	$ 1,362,100	$ (26,774,667)
Ending balance, Shares at Sep. 30, 2021		8,625,000

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2021
Cash Flows from Operating Activities:
Net Income	$ 6,404,577
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liabilities and forward purchase agreement	(11,335,246)
Interest and dividends earned on marketable securities held in Trust Account	(26,384)
Offering costs allocated to derivative warrant liabilities	750,743
Share-based compensation and offering costs on Founder Shares issued to related party and directors	1,397,741
General and administrative expenses paid by related party	11,775
Changes in operating assets and liabilities
Prepaid expenses	(725,543)
Other assets	(260,400)
Accounts payable	180,397
Franchise tax payable	119,400
Accrued expenses	1,339,494
Net cash used in operating activities	(2,143,446)
Cash Flows from Investing Activities:
Investment of cash into Trust Account	(345,000,000)
Net cash used in investing activities	(345,000,000)
Cash Flows from Financing Activities:
Repayment of Sponsor loan	(188,149)
Working capital loan from related party	399,702
Proceeds from Initial Public Offering, net of underwriters’ fees	338,100,000
Proceeds from Private Placement Warrants	9,400,000
Payment of other offering costs	(459,933)
Net cash provided by financing activities	347,251,620
Net increase in cash	108,174
Cash - beginning of period	24,980
Cash - end of period	133,154
Supplemental disclosure of noncash financing activities:
Deferred underwriting fees payable	12,075,000
Deferred offering costs included in accounts payable	14,999
Deferred offering costs included in accrued expenses	15,763
Deferred offering costs paid through promissory note – related party	(176,374)
Deferred offering costs in accrued offering costs and accounts payable at December 31, 2020	369,379
Offering costs associated with Founder Shares issued to related party included in APIC	$ 2,457,259

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1—Description of Organization and Business Operations ECP Environmental Growth Opportunities Corp. (the “Company”) is a blank check company formed as a Delaware corporation on October 29, 2020. The Company was incorporated for the purpose of effecting a merger, As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company has selected December 31 as its fiscal year end. On February 11, 2021, the Company consummated its Initial Public Offering of 34,500,000 units (the “Units”), including 4,500,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $345,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company completed two private sales of an aggregate 6,266,667 warrants (the “Private Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant (the “Private Placements”), to ENNV Holdings, LLC (the “Sponsor”) and Goldman Sachs Asset Management, L.P. (“GSAM”), in its capacity as investment adviser on behalf of its clients (the “GSAM Client Accounts”), generating aggregate gross proceeds to the Company of $9,400,000, which is described in Note 4. Offering costs consist of legal, accounting, underwriting and other costs incurred through the condensed consolidated balance sheet date that are directly related to the Initial Public Offering. Upon the completion of the Initial Public Offering in February 2021, the offering costs totaling $19,606,427 were allocated between stockholders’ equity ($18,855,685) and other expenses ($750,743) based on the fair value of warrant liabilities relative to the Initial Public Offering proceeds recognized in stockholders’ equity. During the quarter ended June 30, 2021, an additional $2.5 million in offering costs were recognized on Founder Shares issued to related party, as well as approximately $35,000 additional cash offering costs. Following the closing of the Initial Public Offering on February 11, 2021, an amount of $345,000,000 ($10.00 per Unit) comprised of $338,100,000 of the proceeds from the Initial Public Offering, including $12,075,000 of the underwriters’ deferred discount, and $6,900,000 of the proceeds from the Private Placements were placed in a U.S.-based trust account at Morgan Stanley Smith Barney LLC maintained by American Stock Transfer & Trust Company, LLC, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its franchise and income taxes and expenses relating to the administration of the trust account, the proceeds from the Initial Public Offering and the Private Placements held in the trust account will not be released until the earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within 24 months from the closing of the Initial Public Offering or (ii) with respect to any other provisions relating to stockholders’ rights or pre-initial Business Combination activity, and (c) the redemption of all of the Company’s public shares if it is unable to complete its Business Combination within 24 months from the closing of the Initial Public Offering, subject to applicable law. On July 18, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Merger Sub, and Fast Radius, Inc., a Delaware corporation (“Fast Radius”), pursuant to which Merger Sub will merge with and into Fast Radius, with Fast Radius surviving such merger as a wholly owned subsidiary of the Company (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”). At the closing of the Merger (the “Closing”), the Company will be renamed “Fast Radius, Inc.” The Business Combination is expected to be consummated in the fourth quarter of 2021, subject to the fulfillment of certain customary closing conditions. Subject to the terms of the Merger Agreement, the aggregate merger consideration with respect to all holders of Fast Radius securities outstanding immediately prior to the Closing, which will be issued in the form of shares or equity awards relating to shares of Class A common stock, will equal 100,000,000 shares of Class A common stock at a deemed value of $10.00 per share (the “Aggregate Merger Consideration”). The Aggregate Merger Consideration will be issued to holders of Fast Radius securities at the Closing in accordance with the Merger Agreement, except that the issuance to holders of Fast Radius capital stock and Vested RSUs (as defined in the Merger Agreement) of a portion of the Aggregate Merger Consideration in an amount equal to 10,000,000 shares of Class A common stock (the “Fast Radius Earn Out Shares”) will be subject to the satisfaction of certain price targets set forth in the Merger Agreement during the five-year combined company following Closing specified in the Merger Agreement (any such event, an “Acquiror Sale”). In the event of an Acquiror Sale in which the per share consideration received is less than a price target set forth in the Merger Agreement that has not previously occurred, the applicable provisions of the Merger Agreement will terminate and no Fast Radius Earn Out Shares will be issuable thereunder with respect to such price target in connection with or following completion of such Acquiror Sale. The Fast Radius Earn Out Shares will be issuable in two equal tranches of 5,000,000 shares of Class A common stock at the time that the Class A common stock reaches a value, as calculated above, of $ 15.00 and $ 20.00 , respectively, and will be allocated among the applicable holders of Fast Radius capital stock and Vested RSUs on a pro rata basis in accordance with the Merger Agreement. In connection with the Closing, the shares (the “Founder Shares”) of Class B common stock issued prior to the Company’s initial public offering that are held by the Sponsor, our independent directors and GSAM will automatically convert into shares of Class A common stock on a one-for-one basis (the “Converted Shares”). 10% of the Converted Shares held by the Sponsor (the “Sponsor Earn Out Shares”) will be subject to vesting upon the satisfaction of certain price targets set forth in the sponsor support agreement the Company entered into with the Sponsor and its independent directors concurrently with the execution of the Merger Agreement (the “Sponsor Support Agreement”) during the Earn Out Period, which price targets will be based upon the (i) the daily volume-weighted average sale price of shares of Class A common stock quoted on NASDAQ, or the exchange on which the shares of Class A common stock are then traded, for any 20 trading days within any 30 consecutive trading day period within the Earn Out Period or (ii) the per share consideration received in connection with an Acquiror Sale. In the event of an Acquiror Sale in which the per share consideration received is less than a price target set forth in the above that has not previously occurred, the applicable provisions of the Sponsor Support Agreement will terminate and no Sponsor Earn Out Shares will be issuable thereunder with respect to such price target in connection with or following completion of such Acquiror Sale. The Sponsor Earn Out Shares will vest in two equal tranches of 407,000 shares of Class A common stock at the time that the Class A common stock reaches a value, as calculated above, of $15.00 and $20.00, respectively. In connection with the execution of the Merger Agreement, the Company entered into subscription agreements (collectively, the “Subscription Agreements”) with certain investors, including the Sponsor (collectively, the “PIPE Investors”), pursuant to which the PIPE Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to the PIPE Investors, an aggregate of 7,500,000 shares of Class A common stock (1,000,000 shares of which will be issued and sold to the Sponsor in its capacity as a PIPE Investor) for a purchase price of $10.00 per share, or an aggregate of $75,000,000, in a private placement (the “PIPE Investment”). The closing of the PIPE Investment will occur substantially concurrently with the consummation of the Business Combination and is conditioned thereon and on other customary closing conditions. The shares of Class A common stock to be issued pursuant to the Subscription Agreements will not be registered under the Securities Act and will be issued in reliance upon the exemption provided under Section 4(a)(2) of the Securities Act. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended, or the Investment Company Act. Upon the closing of the Initial Public Offering, an amount equal to at least $10.00 per Unit sold in the Initial Public Offering, including the proceeds of the Private Placement Warrants, are held in a trust account (“Trust Account”) with the American Stock Transfer & Trust Company acting as trustee and invested in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company will provide its holders of the public shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the transaction. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares prior to this Initial Public Offering (the “Initial Stockholders”) have agreed to vote their Foun der Shares (as defined in Note 5 ) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Company’s Amended and Restated Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock without the prior consent of the Company. The Company’s Sponsor, executive officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their Class A common stock in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes (less up to $100,000 of interest to pay dissolution expenses). The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of September 30, 2021, the Company had $133,154 of cash outside of the Trust Account and a working capital deficit of $1,211,058. On July 30, 2021, the Company issued an unsecured promissory note (the “Note”) in the principal amount of $1,500,000 to an affiliate of the Sponsor, which may be drawn down by the Company from time to time upon written notice to the lender. The Note does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the Note shall not be repaid and all amounts owed under it will be forgiven. Upon the consummation of a Business Combination, the holder of the Note (or a permitted assignee) shall have the option, but not the obligation, to convert all or a portion of the unpaid principal balance of the Note into that number of warrants to purchase one share of Class A Common Stock, $ 0.0001 par value per share, of the Company (the “Working Capital Warrants”) equal to the principal amount of the Note so converted divided by $ 1.50 . The terms of the Working Capital Warrants will be identical to the terms of the warrants issued by the Company to the Sponsor in a private placement that took place sim ultaneously with the Company’s Initial Public O ffering. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. As of September 3 0, 2021, the $ 399,702 drawn against the Note has not been converted to warrants . If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity condition and date for mandatory liquidation and dissolution raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date these consolidated financial statements were issued. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, cash flows and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Restatement of Previously Issue

Restatement of Previously Issued Consolidated Financial Statements	9 Months Ended
	Sep. 30, 2021
Prior Period Adjustment [Abstract]
Restatement of Previously Issued Consolidated Financial Statements	Note 2—Restatement of Previously Issued Consolidated Financial Statements In connection with the preparation of the Company’s condensed consolidated financial statements as of and for the period ended September 30, 2021, management determined it should restate its previously reported financial statements. The Company determined, at the closing of the Company’s Initial Public Offering and when shares were sold pursuant to the exercise of the underwriters’ overallotment, it had improperly classified its Class A common stock subject to possible redemption. The Company previously determined the Class A common stock subject to possible redemption to be equal to the redemption value of $10.00 per Class A common stock while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001, due to the NASDAQ’s minimum net tangible asset requirement. Management determined that the Class A common stock issued during the Initial Public Offering and pursuant to the exercise of the underwriters’ overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the redemption value should include all Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has recorded a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock. Additionally, the condensed consolidated statements of operations has changes solely related to weighted average shares and earnings (loss) per share. There has been no change in the Company’s total assets, liabilities, or operating results. The impact of the restatement on the Company’s consolidated financial statements included in its Form 10-Q for the period ending June 30, 2021 as filed with the SEC on August 20, 2021, and Form 10-Q for the period ending March 31, 2021 as filed with the SEC on May 24, 2021 is reflected in the following table: As of June 30, 2021 As Previously Condensed Consolidated Balance Sheet Reported Adjustment As Restated Common stock subject to possible redemption $ 305,933,489 $ 39,066,511 $ 345,000,000 Stockholders' equity (deficit) Class A common stock - $0.0001 par value 391 (391) — Additional paid-in capital 10,278,770 (8,916,670) 1,362,100 Accumulated deficit (5,280,021) (30,149,451) (35,429,470) Total Stockholders' equity (deficit) $ 5,000,003 $ (39,066,512) $ (34,066,507) Three Months Ended June 30, 2021 As Previously Condensed Consolidated Statement of Operations Reported Adjustment As Restated Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted 31,475,333 3,024,667 34,500,000 Weighted average shares outstanding of Class A and B non-redeemable common stock, basic and diluted 11,649,667 (11,649,667) — Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted — 8,625,000 8,625,000 Basic and diluted earnings (net loss) per share, Class A common stock subject to possible redemption $ 0.00 $ (0.24) $ (0.24) Basic and diluted earnings (net loss) per share of non-redeemable common stock, Class A and B $ (0.88) $ 0.88 $ 0.00 Basic and diluted earnings (net loss) per share, Class B non-redeemable common stock $ 0.00 $ (0.24) $ (0.24) Six Months Ended June 30, 2021 As Previously Condensed Consolidated Statement of Operations Reported Adjustment As Restated Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted 31,177,650 (4,492,567) 26,685,083 Weighted average shares outstanding of Class A and B non-redeemable common stock, basic and diluted 11,692,516 (11,692,516) — Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted — 8,370,166 8,370,166 Basic and diluted earnings (net loss) per share, Class A common stock subject to possible redemption $ 0.00 $ (0.06) $ (0.06) Basic and diluted earnings (net loss) per share of non-redeemable common stock, Class A and B $ (0.19) $ 0.19 $ 0.00 Basic and diluted earnings (net loss) per share, Class B non-redeemable common stock $ 0.00 $ (0.06) $ (0.06) Three Months Ended June 30, 2021 Condensed Consolidated Statement of Changes in Stockholders' Deficit As Previously Reported Adjustment As Restated Offering costs $ (35,641) $ 35,641 $ — Share-based compensation and offering costs on Founder Shares issued to related party and directors 1,397,741 1,249,759 2,647,500 Change in value of common stock subject to possible redemption 8,916,760 (8,916,760) — Accretion of Class A Common Stock to redemption value — (1,285,400) (1,285,400) Six Months Ended June 30, 2021 Condensed Consolidated Statement of Changes in Stockholders' Deficit As Previously Reported Adjustment As Restated Sale of Units in initial public offering, less fair value of public warrants $332,119,425 $ (332,119,425) $ — Offering costs (18,891,326) 18,891,326 — Forward purchase agreement (1,508,461) 1,508,461 — Common stock subject to possible redemption (314,850,250) 314,850,250 — Share-based compensation and offering costs on Founder Shares issued to related party and directors 1,397,741 1,249,759 2,647,500 Change in value of common stock subject to possible redemption 8,916,760 (8,916,760) — Accretion of Class A Common Stock to redemption value — (34,530,121) (34,530,121) As of March 31, 2021 As Previously Condensed Balance Sheet Reported Adjustment As Restated Common stock subject to possible redemption $ 314,850,250 $ 30,149,750 $ 345,000,000 Stockholders' equity (deficit) Class A common stock - $0.0001 par value 301 (301) — Retained earnings (Accumulated deficit) 4,998,844 (30,149,449) (25,150,605) Total Stockholders' equity (deficit) $ 5,000,008 $ (30,149,750) $ (25,149,742) Three Months Ended March 31, 2021 As Previously Condensed Statement of Operations Reported Adjustment As Restated Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted 30,625,007 (11,841,674) 18,783,333 Weighted average shares outstanding of Class A and B non-redeemable common stock, basic and diluted 10,754,314 (10,754,314) — Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted — 8,112,500 8,112,500 Basic and diluted earnings (net loss) per share, Class A common stock subject to possible redemption $ 0.00 $ 0.30 $ 0.30 Basic and diluted earnings (net loss) per share of non-redeemable common stock, Class A and B $ 0.74 $ (0.74) $ 0.00 Basic and diluted earnings (net loss) per share, Class B non-redeemable common stock $ 0.00 $ 0.30 $ 0.30 Three Months Ended March 31, 2021 Condensed Statement of Changes in Stockholders' Deficit As Previously Reported Adjustment As Restated Sale of Units in initial public offering, less fair value of public warrants $ 332,119,425 $ (332,119,425) $ — Offering costs (18,855,685) 18,855,685 — Forward purchase agreement (1,508,461) 1,508,461 — Common stock subject to possible redemption (314,850,250) 314,850,250 — Accretion of Class A Common Stock to redemption value — (33,244,721) (33,244,721) As of February 11, 2021 As Previously Condensed Balance Sheet Reported Adjustment As Restated Common stock subject to possible redemption $ 306,070,895 $ 38,929,105 $ 345,000,000 Stockholders' equity (deficit) Class A common stock - $0.0001 par value 389 (389) — Additional paid-in capital 5,749,492 (5,749,492) — Retained earnings (Accumulated deficit) (750,742) (33,179,224) (33,929,966) Total Stockholders' equity (deficit) $ 5,000,002 $ (38,929,105) $ (33,929,103)

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals and recurring adjustments) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with Company’s prospectus for its Initial Public Offering as filed with the SEC on February 10, 2021 and Form 10-Q filed with the SEC on May 24, 2021. Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Merger Sub, as of September 30, 2021. Merger Sub had no assets or liabilities as of September 30, 2021. All significant intercompany transactions and balances have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $133,154 in cash and no cash equivalents, outside of the funds held in the Trust Account, as of September 30, 2021. Derivative Financial Instruments The Company accounts for the Warrants, Forward Purchase Agreement (as defined below), and Working Capital Loan conversion option (collectively, the “Instruments”) in accordance with the guidance contained in ASC 815-40 under which the Instruments do not meet the criteria for equity treatment and must be recorded as liabilities. The conversion feature within the Working Capital Loan gives the Sponsor an option to convert the loan to warrants of the Company’s Class A common stock. This bifurcated feature is assessed at the end of each reporting period to conclude whether additional liability should be recorded. The Instruments are subjected to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. See Note 6 and 7 for further discussion of the pertinent terms of the Warrants and Forward Purchase Agreement and Note 9 for further discussion of the methodology used to determine the value of the Warrants, Forward Purchase Agreement, and Working Capital Loan conversion option. Cash and Marketable Securities Held in Trust Account At September 30, 2021, the assets held in the Trust Account were invested in money market funds. Class A The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as shareholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2021, 34,500,000 shares of Class A common stock subject to possible redemption are presented as temporary equity outside of the shareholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. From the period beginning January 1, 2021 through September 30, 2021, the Company recorded accretion of Class A common stock to the redemption value in the amount of $34,530,121. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Financial Instruments Except for the Warrant, Forward Purchase Agreement, and Working Capital Loan Liabilities as described above, the fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (the “FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed consolidated balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of September 30, 2021, the carrying values of cash, prepaid expenses, other current assets, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised of money market funds. The fair values of Forward Purchase Agreement and Private Placement Warrants have been estimated using the trading price of the Public Warrants. Public Warrants are valued based on quoted price in active markets. See Note 6 and 7 for further discussion of the pertinent terms of the Warrants and Forward Purchase Agreement and Note 9 for further discussion of the methodology used to determine the value of the Warrants and Forward Purchase Agreement. Offering Costs Offering costs consist of legal, accounting, underwriting and other costs incurred through the condensed consolidated balance sheet date that are directly related to the Initial Public Offering. Upon the completion of the Initial Public Offering in February 2021, the offering costs were allocated using the relative fair values of the company common stock and its Warrants. The costs allocated to Warrants were recognized in other expenses and those related to the Company's common stock were charged to temporary equity. Earnings Per Share of Common Stock Earnings per share of common stock is computed by dividing net earnings (or loss) by the weighted average number of shares issued and outstanding during the period. The Company has not considered the effect of their Forward Purchase Agreement, warrants sold in the Initial Public Offering, private placement to purchase Class A common stock , and Working Capital Loan warrants in the calc ulation of diluted income per share, since the instruments are not dilutive . At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method. As a result, diluted income per share is the same as basic income per share for the periods presented. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock (the “Founder Shares”). Earnings are shared pro rata between the two classes of shares as long as an Initial Business Combination is consummated. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. A reconciliation of the earnings per share is below: For the Three Months Ended September 30, 2021 For the Nine Months Ended September 30, 2021 Numerator: Earnings allocable to Redeemable Class A Common Stock Net Earnings allocable to Redeemable Class A Common Stock $ 6,923,842 $ 4,970,883 Denominator: Weighted Average Share Outstanding, Redeemable Class A Common Stock Basic and diluted weighted average shares outstanding, Redeemable Class A 34,500,000 29,318,681 Basic and diluted net earnings per share, Redeemable Class A $ 0.20 $ 0.17 Non-Redeemable Class B Common Stock Numerator: Net Income allocable to Non-Redeemable Net Earnings Net Income allocable to Non-Redeemable Class B Common Stock $ 1,730,961 $ 1,433,694 Denominator: Weighted Average Non-Redeemable Class B Common Stock Basic and diluted weighted average shares outstanding, Non-Redeemable Class B 8,625,000 8,456,044 Basic and diluted net earnings per share, Non-Redeemable Class B $ 0.20 $ 0.17 Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the United States is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company’s provision for income taxes and deferred tax assets were deemed to be de minimis as of September 30, 2021 and December 31, 2020. Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require only separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Initial Public Offering	Note 4—Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 34,500,000 Units at a purchase price of $10.00 per Unit, including 4,500,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. Each Unit consists of one share of Class A common stock and one-quarter of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 7). Simultaneously with the closing of the Initial Public Offering, the Company completed two private sales of an aggregate 6,266,667 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant, to the Sponsor and GSAM, in its capacity as investment adviser on behalf of the GSAM Client Accounts, generating aggregate gross proceeds to the Company of $9,400,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the Initial Public Offering, except that the Sponsor and GSAM have agreed not to transfer, assign, or sell any of the Private Placement Warrants (except to certain permitted transferees) until 30 days after the completion of the Company’s initial Business Combination. So long as the Private Placement Warrants are held by the Sponsor, GSAM, the GSAM Client Accounts or their permitted transferees, the Private Placement Warrants will not be redeemable for cash by the Company and will be exercisable on a cashless basis.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5—Related Party Transactions Founder Shares On December 8, 2020, the Sponsor paid an aggregate of $25,000 in exchange for the issuance of 8,625,000 shares of Class B common stock (the “Founder Shares”). On December 23, 2020, the Company effected a 6-for-5 reverse stock split with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 7,187,500 Founder Shares. On January 26, 2021, the Company effectuated a 5-for-6 Compensation – Stock Compensation Compensation – Stock Compensation The holders of the Founder Shares agreed to forfeit up to an aggregate of 1,125,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional shares is not exercised in full by the underwriters. As the underwriters’ option to purchase additional shares was exercised in full, forfeiture of Founder Shares did not occur. The Initial Stockholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (1) one year after the completion of the initial Business Combination and (2) the date on which the Company consummates a liquidation, merger, capital stock exchange, reorganization, or other similar transaction after the initial Business Combination that results in all stockholders having the right to exchange their shares of common stock for cash, securities or other property (the “lock-up”). Notwithstanding the foregoing, if the last reported sale price of common stock shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the lock-up. Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans” or “Note”). On July 30, 2021, the Company issued an unsecured promissory note in the principal amount of $1,500,000 to an affiliate of the Sponsor, which may be drawn down by the Company from time to time upon written notice to the lender. The Note does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the Note shall not be repaid and all amounts owed under it will be forgiven. Upon the consummation of a Business Combination, the holder of the Note (or a permitted assignee) shall have the option, but not the obligation, to convert all or a portion of the unpaid principal balance of the Note into that number of Working Capital Warrants equal to the principal amount of the Note so converted divided by $1.50. The conversion option should be bifurcated and accounted for as a derivative in accordance with ASC 815. However, the exercise price of the underlying warrants was greater than the warrant fair value as of September 30, 2021, and when the Note was drawn on. The Company believes that the likelihood of the Sponsor’s exercise of the option to convert the Note to warrants is de minimis. As a result, the Company recorded zero liability related to the conversion option. The terms of the Working Capital Warrants will be identical to the terms of the warrants issued by the Company to the Sponsor in a private placement that took place simultaneously with the Company’s Initial Public Offering. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. As of September 30, 2021, there was a balance of $399,702 under this loan. Administrative Services Agreement The Company entered into an Administrative Services Agreement pursuant to which the Company will pay an affiliate of our Sponsor a total of $10,000 per month, until the earlier of the completion of the initial Business Combination and the liquidation of the trust assets, for office space, utilities, administrative and support services. Upon completion of the initial Business Combination or liquidation, the Company will cease paying these monthly fees. For the three and nine months ended September 30, 2021, the Company expensed $30,000 and $77,143 in monthly administrative support services, respectively, with $10,000 and $0 of these expenses included in accrued expenses as of September 30, 2021 and December 31, 2020, respectively. Due to Related Party On January 26, 2021, the Company entered into a promissory note pursuant to which Energy Capital Partners Management, LP (“ECP”) agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. The promissory note was repaid in full upon the Initial Public Offering.

Commitments & Contingencies

Commitments & Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 6—Commitments & Contingencies Registration and Stockholder Rights The holders of the Founder Shares, Private Placement Warrants, and Working Capital Warrants that may be issued upon conversion of the amounts due under the Note at the time the Company consummates a Business Combination (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights pursuant to a registration and stockholder rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In the event of any delay in filing and/or effectiveness of the registration statement required pursuant to the registration and stockholder rights agreement, or after the effective date, such registration statement ceases for any reason to remain continuously effective (each, a “Registration Default”), the holders will be entitled to payments from the Company equal to 2% of the purchase price on the occurrence of each registration default and 2% per month that such registration default continues to exist, as more fully described in the registration and stockholder rights agreement. Underwriting Agreement The Company granted the underwriters an option to cover over-allotments and for market stabilization purposes. The over-allotment option entitled the underwriters to purchase on a pro rata basis up to 4,500,000 additional Units at the Initial Public Offering price, less the underwriting discounts and commissions. On the date of the Initial Public Offering, the underwriters exercised the over-allotment option in full, purchasing 4,500,000 Units. The underwriters are entitled to a deferred fee of $0.35 per Unit, or $12,075,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreement On January 24, 2021, the Company entered into a Forward Purchase Agreement with GSAM, in its capacity as investment adviser on behalf of the GSAM Client Accounts, as amended by the First Amendment to Forward Purchase Agreement, dated as of January 31, 2021 (as so amended, the “Forward Purchase Agreement”), pursuant to which the GSAM Client Accounts committed to purchase an aggregate of up to 5,000,000 forward purchase units (the “Forward Purchase Units”), consisting of one share of the Company’s Class A common stock (the “Forward Purchase Shares”) and one-quarter Concurrently with the execution of the Merger Agreement on July 18, 2021, the Company, the Sponsor and GSAM, in its capacity as investment adviser on behalf of the GSAM Client Accounts, The Company and the Sponsor also waived GSAM’s potential obligation to forfeit shares of Class B common stock under the circumstances contemplated by the Forward Purchase Agreement in connection with the Closing

Warrant Liabilities

Warrant Liabilities	9 Months Ended
	Sep. 30, 2021
Warrants And Rights Note Disclosure [Abstract]
Warrant Liabilities	Note 7—Warrant Liabilities Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $ 9.20 per common share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “ Market Value ”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115 % of the higher of the Market Value and the Newly Issued Price, and the $ 18.00 per share redemption trigger price described under “ Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180 % of the higher of the Market Value and the Newly Issued Price, and the $ 10.00 per share redemption trigger price described under the caption “ Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable and can be exercised on a cashless basis so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Stockholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00: When the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price (the “closing price”) of shares of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00: When the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to an agreed table based on the redemption date and the “fair market value” of shares of Class A common stock; and • if, and only if, the last reported sale price of Class A common stock equals or exceeds $10.00 per share (as adjusted) on the trading day prior to the date on which of redemption is sent to the warrant holders; and • if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The “fair market value” shall mean the volume-weighted average price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. Forward Purchase Warrants have the same terms as the Public Warrants, except the Forward Purchase Warrants will be subject to transfer restrictions and certain registration rights. The company accounts for the Public Warrants, Private Placement Warrants and Forward Purchase Agreement in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant and forward purchase unit that includes a warrant must be recorded as a liability.

Stockholders_ Deficit

Stockholders’ Deficit	9 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Stockholders' Deficit	Note 8—Stockholders’ Deficit Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2021, there were no shares of preferred stock issued or outstanding. Class A Common Stock — The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. At September 30, 2021, there were 34,500,000 shares of Class A common stock issued and outstanding subject to possible redemption. Class B Common Stock — The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. On December 23, 2020, the Company effected a 6-for-5 5-for-6 Only holders of Class B common stock will have the right to vote on the election of directors and to remove directors prior to the initial Business Combination, and such rights may only be amended by a resolution passed by the holders of a majority of Class B common stock. On all other matters submitted to a vote of the Company’s stockholders, holders of the Class B common stock and holders of the Class A common stock will vote together as a single class, with each share of common stock entitling the holder to one vote, except as required by law or the applicable rules of the NASDAQ Capital Market (“NASDAQ”), then in effect. For so long as shares of Class B common stock remain outstanding, the Company may not amend, alter, or repeal any provision of its amended and restated certificate of incorporation in any manner that would alter or change the powers, preferences, or relative participating, optional or other special rights of the Class B common stock without the prior written consent of the holders of a majority of the shares of Class B common stock then outstanding. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to increase in respect of the issuance of certain securities. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amount issued in this offering and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the aggregate number of all shares of common stock outstanding upon the completion of this offering, plus the aggregate number of shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination, any shares or equity-linked securities issued (or to be issued), and any private placement warrants issued.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9—Fair Value Measurements The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2021 including the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Description Level Fair Value September 30, 2021 Marketable securities 1 $ 345,026,384 The Warrants and Forward Purchase Agreement are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants and Forward Purchase Agreement are recorded in the statement of operations each period. The following table presents the fair value hierarchy for liabilities measured at fair value on a recurring basis as of September 30, 2021: Level 1 Level 2 Level 3 Total Derivative liabilities: Public Warrants $ 7,131,150 $ — $ — $ 7,131,150 Private Placement Warrants — 5,181,280 — 5,181,280 Forward Purchase Agreement — — 100,000 100,000 Total liabilities $ 7,131,150 $ 5,181,280 $ 100,000 $ 12,412,430 On April 1, 2021, the Public Warrants surpassed the 52-day threshold waiting period to be publicly traded in accordance with the Prospectus filed February 10, 2021. Once publicly traded, the observable input qualifies the liability for treatment as a Level 1 liability. As such, as of September 30, 2021, the Company classified the Public Warrants as Level 1. The Private Warrants were valued based on the trading price of Public Warrants, which is considered to be a Level 2 fair value measurement. To estimate the value of the Private Placement Warrants, the Company used the public trading price of the Public Warrants. This value was adjusted to reflect the value of the issuer call provision of the Public Warrants, as this right is not applicable to the Private Placement Warrants unless they are sold by the initial holders. At September 30, 2021, Forward Purchase Units were valued equal to the difference between the current public trading price and the purchase price, as the Forward Purchase Agreement requires the purchase of units for $ 10 upon a completion of the Business Combination. The Company previously valued the Forward Purchase Agreement based on the trading price of the Public Warrants, which was considered Level 2 as there was an exercise option prior to the issuance of the Side Letter . As such, the Company transferred the Forward Purchase Agreement from a Level 2 to a Level 3 liability , due to the use of the updated valuation method discussed above which includes a significant unobservable input , and factoring in assumption of the closing of the Business Combination . Outside of the transfer of the Forward Purchase Agreement from Level 2 to Level 3, there were no transfers between Levels 1, 2, and 3 during the three months ended September 30, 2021. The following table presents a summary of the changes in the fair value of the Derivative Liabilities: Public Warrant Private Warrant Forward purchase Liability Liability Agreement Total Fair value, February 11, 2021 $ 12,880,575 $ 9,358,640 $ 1,508,461 $ 23,747,676 Recognized gain on change in fair value 4,953,337 3,598,947 503,029 9,055,313 Fair value, March 31, 2021 $ 7,927,238 $ 5,759,693 $ 1,005,432 $ 14,692,363 Recognized loss on change in fair value (4,147,762) (3,013,640) (743,318) (7,904,720) Fair value, June 30, 2021 $ 12,075,000 $ 8,773,333 $ 1,748,750 $ 22,597,083 Recognized gain on change in fair value 4,943,850 3,592,053 1,648,750 10,184,653 Fair value, September 30, 2021 $ 7,131,150 $ 5,181,280 $ 100,000 $ 12,412,430

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 10—Subsequent events The Company evaluated subsequent events and transactions that occurred after the condensed consolidated balance sheet date through the date the condensed consolidated financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals and recurring adjustments) considered for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with Company’s prospectus for its Initial Public Offering as filed with the SEC on February 10, 2021 and Form 10-Q filed with the SEC on May 24, 2021.
Principles of Consolidation	Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Merger Sub, as of September 30, 2021. Merger Sub had no assets or liabilities as of September 30, 2021. All significant intercompany transactions and balances have been eliminated in consolidation.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $133,154 in cash and no cash equivalents, outside of the funds held in the Trust Account, as of September 30, 2021.
Derivative Financial Instruments	Derivative Financial Instruments The Company accounts for the Warrants, Forward Purchase Agreement (as defined below), and Working Capital Loan conversion option (collectively, the “Instruments”) in accordance with the guidance contained in ASC 815-40 under which the Instruments do not meet the criteria for equity treatment and must be recorded as liabilities. The conversion feature within the Working Capital Loan gives the Sponsor an option to convert the loan to warrants of the Company’s Class A common stock. This bifurcated feature is assessed at the end of each reporting period to conclude whether additional liability should be recorded. The Instruments are subjected to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. See Note 6 and 7 for further discussion of the pertinent terms of the Warrants and Forward Purchase Agreement and Note 9 for further discussion of the methodology used to determine the value of the Warrants, Forward Purchase Agreement, and Working Capital Loan conversion option.
Cash And Marketable Securities Held In Trust Account	Cash and Marketable Securities Held in Trust Account At September 30, 2021, the assets held in the Trust Account were invested in money market funds.
Class A Common Stock Subject to Possible Redemption	Class A The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as shareholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2021, 34,500,000 shares of Class A common stock subject to possible redemption are presented as temporary equity outside of the shareholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit. From the period beginning January 1, 2021 through September 30, 2021, the Company recorded accretion of Class A common stock to the redemption value in the amount of $34,530,121.
Concentrations of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Financial Instruments	Financial Instruments Except for the Warrant, Forward Purchase Agreement, and Working Capital Loan Liabilities as described above, the fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (the “FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the condensed consolidated balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of September 30, 2021, the carrying values of cash, prepaid expenses, other current assets, accounts payable and accrued expenses approximate their fair values due to the short-term nature of the instruments. The Company’s portfolio of marketable securities held in the Trust Account is comprised of money market funds. The fair values of Forward Purchase Agreement and Private Placement Warrants have been estimated using the trading price of the Public Warrants. Public Warrants are valued based on quoted price in active markets. See Note 6 and 7 for further discussion of the pertinent terms of the Warrants and Forward Purchase Agreement and Note 9 for further discussion of the methodology used to determine the value of the Warrants and Forward Purchase Agreement.
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting and other costs incurred through the condensed consolidated balance sheet date that are directly related to the Initial Public Offering. Upon the completion of the Initial Public Offering in February 2021, the offering costs were allocated using the relative fair values of the company common stock and its Warrants. The costs allocated to Warrants were recognized in other expenses and those related to the Company's common stock were charged to temporary equity.
Earnings Per Share of Common Stock	Earnings Per Share of Common Stock Earnings per share of common stock is computed by dividing net earnings (or loss) by the weighted average number of shares issued and outstanding during the period. The Company has not considered the effect of their Forward Purchase Agreement, warrants sold in the Initial Public Offering, private placement to purchase Class A common stock , and Working Capital Loan warrants in the calc ulation of diluted income per share, since the instruments are not dilutive . At September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company under the treasury stock method. As a result, diluted income per share is the same as basic income per share for the periods presented. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock (the “Founder Shares”). Earnings are shared pro rata between the two classes of shares as long as an Initial Business Combination is consummated. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. A reconciliation of the earnings per share is below: For the Three Months Ended September 30, 2021 For the Nine Months Ended September 30, 2021 Numerator: Earnings allocable to Redeemable Class A Common Stock Net Earnings allocable to Redeemable Class A Common Stock $ 6,923,842 $ 4,970,883 Denominator: Weighted Average Share Outstanding, Redeemable Class A Common Stock Basic and diluted weighted average shares outstanding, Redeemable Class A 34,500,000 29,318,681 Basic and diluted net earnings per share, Redeemable Class A $ 0.20 $ 0.17 Non-Redeemable Class B Common Stock Numerator: Net Income allocable to Non-Redeemable Net Earnings Net Income allocable to Non-Redeemable Class B Common Stock $ 1,730,961 $ 1,433,694 Denominator: Weighted Average Non-Redeemable Class B Common Stock Basic and diluted weighted average shares outstanding, Non-Redeemable Class B 8,625,000 8,456,044 Basic and diluted net earnings per share, Non-Redeemable Class B $ 0.20 $ 0.17
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the United States is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company’s provision for income taxes and deferred tax assets were deemed to be de minimis as of September 30, 2021 and December 31, 2020.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require only separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Consolidated Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2021
Prior Period Adjustment [Abstract]
Summary of Impact of Restatement on Consolidated Financial Statement	The impact of the restatement on the Company’s consolidated financial statements included in its Form 10-Q for the period ending June 30, 2021 as filed with the SEC on August 20, 2021, and Form 10-Q for the period ending March 31, 2021 as filed with the SEC on May 24, 2021 is reflected in the following table: As of June 30, 2021 As Previously Condensed Consolidated Balance Sheet Reported Adjustment As Restated Common stock subject to possible redemption $ 305,933,489 $ 39,066,511 $ 345,000,000 Stockholders' equity (deficit) Class A common stock - $0.0001 par value 391 (391) — Additional paid-in capital 10,278,770 (8,916,670) 1,362,100 Accumulated deficit (5,280,021) (30,149,451) (35,429,470) Total Stockholders' equity (deficit) $ 5,000,003 $ (39,066,512) $ (34,066,507) Three Months Ended June 30, 2021 As Previously Condensed Consolidated Statement of Operations Reported Adjustment As Restated Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted 31,475,333 3,024,667 34,500,000 Weighted average shares outstanding of Class A and B non-redeemable common stock, basic and diluted 11,649,667 (11,649,667) — Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted — 8,625,000 8,625,000 Basic and diluted earnings (net loss) per share, Class A common stock subject to possible redemption $ 0.00 $ (0.24) $ (0.24) Basic and diluted earnings (net loss) per share of non-redeemable common stock, Class A and B $ (0.88) $ 0.88 $ 0.00 Basic and diluted earnings (net loss) per share, Class B non-redeemable common stock $ 0.00 $ (0.24) $ (0.24) Six Months Ended June 30, 2021 As Previously Condensed Consolidated Statement of Operations Reported Adjustment As Restated Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted 31,177,650 (4,492,567) 26,685,083 Weighted average shares outstanding of Class A and B non-redeemable common stock, basic and diluted 11,692,516 (11,692,516) — Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted — 8,370,166 8,370,166 Basic and diluted earnings (net loss) per share, Class A common stock subject to possible redemption $ 0.00 $ (0.06) $ (0.06) Basic and diluted earnings (net loss) per share of non-redeemable common stock, Class A and B $ (0.19) $ 0.19 $ 0.00 Basic and diluted earnings (net loss) per share, Class B non-redeemable common stock $ 0.00 $ (0.06) $ (0.06) Three Months Ended June 30, 2021 Condensed Consolidated Statement of Changes in Stockholders' Deficit As Previously Reported Adjustment As Restated Offering costs $ (35,641) $ 35,641 $ — Share-based compensation and offering costs on Founder Shares issued to related party and directors 1,397,741 1,249,759 2,647,500 Change in value of common stock subject to possible redemption 8,916,760 (8,916,760) — Accretion of Class A Common Stock to redemption value — (1,285,400) (1,285,400) Six Months Ended June 30, 2021 Condensed Consolidated Statement of Changes in Stockholders' Deficit As Previously Reported Adjustment As Restated Sale of Units in initial public offering, less fair value of public warrants $332,119,425 $ (332,119,425) $ — Offering costs (18,891,326) 18,891,326 — Forward purchase agreement (1,508,461) 1,508,461 — Common stock subject to possible redemption (314,850,250) 314,850,250 — Share-based compensation and offering costs on Founder Shares issued to related party and directors 1,397,741 1,249,759 2,647,500 Change in value of common stock subject to possible redemption 8,916,760 (8,916,760) — Accretion of Class A Common Stock to redemption value — (34,530,121) (34,530,121) As of March 31, 2021 As Previously Condensed Balance Sheet Reported Adjustment As Restated Common stock subject to possible redemption $ 314,850,250 $ 30,149,750 $ 345,000,000 Stockholders' equity (deficit) Class A common stock - $0.0001 par value 301 (301) — Retained earnings (Accumulated deficit) 4,998,844 (30,149,449) (25,150,605) Total Stockholders' equity (deficit) $ 5,000,008 $ (30,149,750) $ (25,149,742) Three Months Ended March 31, 2021 As Previously Condensed Statement of Operations Reported Adjustment As Restated Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted 30,625,007 (11,841,674) 18,783,333 Weighted average shares outstanding of Class A and B non-redeemable common stock, basic and diluted 10,754,314 (10,754,314) — Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted — 8,112,500 8,112,500 Basic and diluted earnings (net loss) per share, Class A common stock subject to possible redemption $ 0.00 $ 0.30 $ 0.30 Basic and diluted earnings (net loss) per share of non-redeemable common stock, Class A and B $ 0.74 $ (0.74) $ 0.00 Basic and diluted earnings (net loss) per share, Class B non-redeemable common stock $ 0.00 $ 0.30 $ 0.30 Three Months Ended March 31, 2021 Condensed Statement of Changes in Stockholders' Deficit As Previously Reported Adjustment As Restated Sale of Units in initial public offering, less fair value of public warrants $ 332,119,425 $ (332,119,425) $ — Offering costs (18,855,685) 18,855,685 — Forward purchase agreement (1,508,461) 1,508,461 — Common stock subject to possible redemption (314,850,250) 314,850,250 — Accretion of Class A Common Stock to redemption value — (33,244,721) (33,244,721) As of February 11, 2021 As Previously Condensed Balance Sheet Reported Adjustment As Restated Common stock subject to possible redemption $ 306,070,895 $ 38,929,105 $ 345,000,000 Stockholders' equity (deficit) Class A common stock - $0.0001 par value 389 (389) — Additional paid-in capital 5,749,492 (5,749,492) — Retained earnings (Accumulated deficit) (750,742) (33,179,224) (33,929,966) Total Stockholders' equity (deficit) $ 5,000,002 $ (38,929,105) $ (33,929,103)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Reconciliation of Earnings Per Share	A reconciliation of the earnings per share is below: For the Three Months Ended September 30, 2021 For the Nine Months Ended September 30, 2021 Numerator: Earnings allocable to Redeemable Class A Common Stock Net Earnings allocable to Redeemable Class A Common Stock $ 6,923,842 $ 4,970,883 Denominator: Weighted Average Share Outstanding, Redeemable Class A Common Stock Basic and diluted weighted average shares outstanding, Redeemable Class A 34,500,000 29,318,681 Basic and diluted net earnings per share, Redeemable Class A $ 0.20 $ 0.17 Non-Redeemable Class B Common Stock Numerator: Net Income allocable to Non-Redeemable Net Earnings Net Income allocable to Non-Redeemable Class B Common Stock $ 1,730,961 $ 1,433,694 Denominator: Weighted Average Non-Redeemable Class B Common Stock Basic and diluted weighted average shares outstanding, Non-Redeemable Class B 8,625,000 8,456,044 Basic and diluted net earnings per share, Non-Redeemable Class B $ 0.20 $ 0.17

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2021 including the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Description Level Fair Value September 30, 2021 Marketable securities 1 $ 345,026,384
Schedule of Liabilities Measured at Fair Value on Recurring Basis	The following table presents the fair value hierarchy for liabilities measured at fair value on a recurring basis as of September 30, 2021: Level 1 Level 2 Level 3 Total Derivative liabilities: Public Warrants $ 7,131,150 $ — $ — $ 7,131,150 Private Placement Warrants — 5,181,280 — 5,181,280 Forward Purchase Agreement — — 100,000 100,000 Total liabilities $ 7,131,150 $ 5,181,280 $ 100,000 $ 12,412,430
Summary of Changes in Fair Value of Derivative Liabilities	The following table presents a summary of the changes in the fair value of the Derivative Liabilities: Public Warrant Private Warrant Forward purchase Liability Liability Agreement Total Fair value, February 11, 2021 $ 12,880,575 $ 9,358,640 $ 1,508,461 $ 23,747,676 Recognized gain on change in fair value 4,953,337 3,598,947 503,029 9,055,313 Fair value, March 31, 2021 $ 7,927,238 $ 5,759,693 $ 1,005,432 $ 14,692,363 Recognized loss on change in fair value (4,147,762) (3,013,640) (743,318) (7,904,720) Fair value, June 30, 2021 $ 12,075,000 $ 8,773,333 $ 1,748,750 $ 22,597,083 Recognized gain on change in fair value 4,943,850 3,592,053 1,648,750 10,184,653 Fair value, September 30, 2021 $ 7,131,150 $ 5,181,280 $ 100,000 $ 12,412,430

Description of Organization a_2

Description of Organization and Business of Operations - Additional Information (Details)	Jul. 18, 2021USD ($)Tranche$ / sharesshares	Feb. 11, 2021USD ($)$ / sharesshares	Feb. 28, 2021USD ($)	Jun. 30, 2021USD ($)$ / shares	Sep. 30, 2021USD ($)Private$ / sharesshares	Jul. 30, 2021USD ($)$ / sharesshares	Mar. 31, 2021$ / shares	Dec. 31, 2020$ / shares
Organization And Basis Of Operations [Line Items]
Entity incorporation date					Oct. 29, 2020
Shares issued, price per share | $ / shares		$ 10
Gross proceeds of shares issued		$ 345,000,000
Purchase price of warrants | $ / shares					$ 11.50
Proceeds from Private Placement Warrants					$ 9,400,000
Initial public offering costs			$ 19,606,427
Offering costs allocated to stockholders' equity			(18,855,685)
Offering costs allocated to derivative warrant liabilities			$ (750,743)		$ (750,743)
Underwriters' deferred discount		$ 12,075,000
Redeemable percentage of public shares					100.00%
Business combination maximum completion period					24 months
Minimum required percentage of net assets held in trust account					80.00%
Minimum target percentage of outstanding voting securities					50.00%
Per unit value of initial public offering, including the proceeds of the private placement warrants, are held in a trust account | $ / shares					$ 10
Minimum net tangible assets to proceed with business combination					$ 5,000,001
Maximum amount of interest to pay dissolution expenses					$ 100,000
Residual assets remaining available for distribution price per share initially held in trust account | $ / shares					$ 10
Protection of amount held in trust account, description					In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Cash outside of trust account					$ 133,154
Working capital deficit					1,211,058
Unsecured Promissory Note
Organization And Basis Of Operations [Line Items]
Principal amount						$ 1,500,000
Number of warrant holder to purchase share | shares						1
Common stock, par value | $ / shares						$ 0.0001
Note convertible price | $ / shares						$ 1.50
Amount drawn against note has not been converted to warrants					$ 399,702
Sponsor Support Agreement
Organization And Basis Of Operations [Line Items]
Number of trading days	20 days
Number of consecutive trading day period	30 days
Number of equal tranches | Tranche	2
Percentage of converted shares help by sponsor	10.00%
Class A Common Stock
Organization And Basis Of Operations [Line Items]
Minimum restricted percentage on redemption of shares					15.00%
Number of warrant holder to purchase share | shares					1
Common stock, par value | $ / shares		$ 0.0001		$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001
Class A Common Stock | Sponsor
Organization And Basis Of Operations [Line Items]
Shares issued | shares	1,000,000
Class A Common Stock | Merger Agreement
Organization And Basis Of Operations [Line Items]
Shares issued | shares	100,000,000
Shares issued, price per share | $ / shares	$ 10
Class A Common Stock | Sponsor Support Agreement
Organization And Basis Of Operations [Line Items]
Shares issued | shares	407,000
Class A Common Stock | Sponsor Support Agreement | Minimum
Organization And Basis Of Operations [Line Items]
Shares issued, price per share | $ / shares	$ 15
Class A Common Stock | Sponsor Support Agreement | Maximum
Organization And Basis Of Operations [Line Items]
Shares issued, price per share | $ / shares	$ 20
Founder Shares
Organization And Basis Of Operations [Line Items]
Initial public offering costs				$ 2,500,000
Additional cash offering costs				$ 35,000
Initial Public Offering
Organization And Basis Of Operations [Line Items]
Shares issued | shares		34,500,000			34,500,000
Shares issued, price per share | $ / shares		$ 10			$ 10
Gross proceeds of shares issued		$ 338,100,000
Initial Public Offering | Class A Common Stock
Organization And Basis Of Operations [Line Items]
Purchase price of warrants | $ / shares					$ 11.50
Over-allotments
Organization And Basis Of Operations [Line Items]
Shares issued | shares		4,500,000			4,500,000
Private Placement Warrants
Organization And Basis Of Operations [Line Items]
Gross proceeds of shares issued		$ 6,900,000
Number of private sales | Private					2
Number of warrants | shares					6,266,667
Purchase price of warrants | $ / shares					$ 1.50
Proceeds from Private Placement Warrants					$ 9,400,000
Private Placement Warrants | Class A Common Stock
Organization And Basis Of Operations [Line Items]
Shares issued | shares	7,500,000
Shares issued, price per share | $ / shares	$ 10
Gross proceeds of shares issued	$ 75,000,000
Fast Radius Capital Stock and Vested RSUs | Merger Agreement
Organization And Basis Of Operations [Line Items]
Merger agreement period	5 years
Number of trading days	20 days
Number of consecutive trading day period	30 days
Fast Radius Capital Stock and Vested RSUs | Class A Common Stock | Merger Agreement
Organization And Basis Of Operations [Line Items]
Shares issued | shares	10,000,000
Fast Radius Earn Out Shares | Merger Agreement
Organization And Basis Of Operations [Line Items]
Number of equal tranches | Tranche	2
Fast Radius Earn Out Shares | Class A Common Stock | Merger Agreement
Organization And Basis Of Operations [Line Items]
Shares issued | shares	5,000,000
Fast Radius Earn Out Shares | Class A Common Stock | Merger Agreement | Minimum
Organization And Basis Of Operations [Line Items]
Shares issued, price per share | $ / shares	$ 15
Fast Radius Earn Out Shares | Class A Common Stock | Merger Agreement | Maximum
Organization And Basis Of Operations [Line Items]
Shares issued, price per share | $ / shares	$ 20

Restatement of Previously Iss_3

Restatement of Previously Issued Consolidated Financial Statements - Additional Information (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total assets	$ 346,145,481	$ 346,145,481	$ 394,359
Total liabilities	26,557,185	26,557,185	$ 369,379
Operating results	(1,534,290)	(2,956,551)
Adjustment
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total assets	0	0
Total liabilities	$ 0	0
Operating results		$ 0
Class A Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption, value	$ 10	$ 10
Minimum net tangible assets	$ 5,000,001	$ 5,000,001

Restatement of Previously Iss_4

Restatement of Previously Issued Consolidated Financial Statements - Summary of Impact of Restatement on Consolidated Financial Statement (Details) - USD ($)	1 Months Ended	3 Months Ended			6 Months Ended	9 Months Ended
	Feb. 28, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021	Feb. 11, 2021	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption			$ 345,000,000	$ 345,000,000	$ 345,000,000		$ 345,000,000
Additional paid-in capital		$ 1,362,100	1,362,100		1,362,100	$ 1,362,100		$ 24,137
Retained earnings (Accumulated deficit)		(26,774,667)	(35,429,470)	(25,150,605)	(35,429,470)	(26,774,667)	(33,929,966)	(20)
Total stockholders' (deficit) equity		(25,411,704)	(34,066,507)	(25,149,742)	(34,066,507)	(25,411,704)	(33,929,103)	$ 24,980
Offering costs allocated to stockholders' equity	$ (18,855,685)
Share-based compensation, cash offering costs, and offering costs on Founder Shares issued to related party and directors			2,647,500		2,647,500
Accretion of Class A Common Stock to redemption value			$ (1,285,400)	$ (33,244,721)	$ (34,530,121)	(34,530,121)
Class A Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption		$ 345,000,000				$ 345,000,000
Class A Common Stock Subject to Possible Redemption
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted			34,500,000	18,783,333	26,685,083
Basic and diluted earnings (net loss) per share			$ (0.24)	$ 0.30	$ (0.06)
Class A and B Non-Redeemable Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted earnings (net loss) per share			$ 0	$ 0	$ 0
Class B Non-Redeemable Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted		8,625,000	8,625,000	8,112,500	8,370,166	8,456,044
Basic and diluted earnings (net loss) per share		$ 0.20	$ (0.24)	$ 0.30	$ (0.06)	$ 0.17
As Previously Reported
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption			$ 305,933,489	$ 314,850,250	$ 305,933,489		306,070,895
Additional paid-in capital			10,278,770		10,278,770		5,749,492
Retained earnings (Accumulated deficit)			(5,280,021)	4,998,844	(5,280,021)		(750,742)
Total stockholders' (deficit) equity			5,000,003	5,000,008	5,000,003		5,000,002
Offering costs allocated to stockholders' equity			(35,641)	(18,855,685)	(18,891,326)
Share-based compensation, cash offering costs, and offering costs on Founder Shares issued to related party and directors			1,397,741		1,397,741
Change in value of common stock subject to possible redemption			8,916,760		8,916,760
Sale of Units in initial public offering, less fair value of public warrants				332,119,425	332,119,425
Forward purchase agreement				(1,508,461)	(1,508,461)
Common stock subject to possible redemption				(314,850,250)	(314,850,250)
As Previously Reported | Class A Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common Stock, Value			$ 391	$ 301	$ 391		389
As Previously Reported | Class A Common Stock Subject to Possible Redemption
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted			31,475,333	30,625,007	31,177,650
Basic and diluted earnings (net loss) per share			$ 0	$ 0	$ 0
As Previously Reported | Class A and B Non-Redeemable Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted			11,649,667	10,754,314	11,692,516
Basic and diluted earnings (net loss) per share			$ (0.88)	$ 0.74	$ (0.19)
As Previously Reported | Class B Non-Redeemable Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Basic and diluted earnings (net loss) per share			$ 0	$ 0	$ 0
Adjustment
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common stock subject to possible redemption			$ 39,066,511	$ 30,149,750	$ 39,066,511		38,929,105
Additional paid-in capital			(8,916,670)		(8,916,670)		(5,749,492)
Retained earnings (Accumulated deficit)			(30,149,451)	(30,149,449)	(30,149,451)		(33,179,224)
Total stockholders' (deficit) equity			(39,066,512)	(30,149,750)	(39,066,512)		(38,929,105)
Offering costs allocated to stockholders' equity			35,641	18,855,685	18,891,326
Share-based compensation, cash offering costs, and offering costs on Founder Shares issued to related party and directors			1,249,759		1,249,759
Change in value of common stock subject to possible redemption			(8,916,760)		(8,916,760)
Accretion of Class A Common Stock to redemption value			(1,285,400)	(33,244,721)	(34,530,121)
Sale of Units in initial public offering, less fair value of public warrants				(332,119,425)	(332,119,425)
Forward purchase agreement				1,508,461	1,508,461
Common stock subject to possible redemption				314,850,250	314,850,250
Adjustment | Class A Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common Stock, Value			$ (391)	$ (301)	$ (391)		$ (389)
Adjustment | Class A Common Stock Subject to Possible Redemption
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted			3,024,667	(11,841,674)	(4,492,567)
Basic and diluted earnings (net loss) per share			$ (0.24)	$ 0.30	$ (0.06)
Adjustment | Class A and B Non-Redeemable Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted			(11,649,667)	(10,754,314)	(11,692,516)
Basic and diluted earnings (net loss) per share			$ 0.88	$ (0.74)	$ 0.19
Adjustment | Class B Non-Redeemable Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Weighted average shares outstanding, basic and diluted			8,625,000	8,112,500	8,370,166
Basic and diluted earnings (net loss) per share			$ (0.24)	$ 0.30	$ (0.06)

Restatement of Previously Iss_5

Restatement of Previously Issued Consolidated Financial Statements - Summary of Impact of Restatement on Consolidated Financial Statement (Parenthetical) (Details) - $ / shares	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 11, 2021	Dec. 31, 2020
Class A Common Stock
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details)	3 Months Ended		6 Months Ended	9 Months Ended
	Jun. 30, 2021USD ($)	Mar. 31, 2021USD ($)	Jun. 30, 2021USD ($)	Sep. 30, 2021USD ($)Classshares	Dec. 31, 2020USD ($)shares
Summary Of Significant Accounting Policies [Line Items]
Total assets				$ 346,145,481	$ 394,359
Total liabilities				26,557,185	369,379
Cash				133,154	$ 24,980
Cash equivalents				0
Accretion of Class A common stock to redemption value	$ 1,285,400	$ 33,244,721	$ 34,530,121	34,530,121
Unrecognized tax benefits				0
Unrecognized tax benefits, accrued for interest and penalties				$ 0
Common Stock
Summary Of Significant Accounting Policies [Line Items]
Number of classes of shares | Class				2
Federal Depository Insurance Coverage
Summary Of Significant Accounting Policies [Line Items]
Concentration of credit risk				$ 250,000
Experienced Losses
Summary Of Significant Accounting Policies [Line Items]
Concentration of credit risk				0
Significant Risks
Summary Of Significant Accounting Policies [Line Items]
Concentration of credit risk				$ 0
Class A Common Stock
Summary Of Significant Accounting Policies [Line Items]
Common stock subject to possible redemption | shares				34,500,000	34,500,000
ENNV Merger Sub, Inc.
Summary Of Significant Accounting Policies [Line Items]
Total assets				$ 0
Total liabilities				$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reconciliation of Earnings Per Share (Details) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021
Summary Of Significant Accounting Policies [Line Items]
Net income (loss)	$ 8,654,803	$ (10,278,865)	$ 8,028,639		$ 6,404,577
Redeemable Class A Common Stock
Summary Of Significant Accounting Policies [Line Items]
Net income (loss)	$ 6,923,842				$ 4,970,883
Weighted average shares outstanding, basic and diluted	34,500,000				29,318,681
Basic and diluted net earnings per share	$ 0.20				$ 0.17
Non-Redeemable Class B Common Stock
Summary Of Significant Accounting Policies [Line Items]
Net income (loss)	$ 1,730,961				$ 1,433,694
Weighted average shares outstanding, basic and diluted	8,625,000	8,625,000	8,112,500	8,370,166	8,456,044
Basic and diluted net earnings per share	$ 0.20	$ (0.24)	$ 0.30	$ (0.06)	$ 0.17

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Details)	Jul. 18, 2021$ / sharesshares	Feb. 11, 2021$ / sharesshares	Sep. 30, 2021USD ($)Private$ / sharesshares
Subsidiary or Equity Method Investee [Line Items]
Shares issued, price per share		$ 10
Purchase price of warrants			$ 11.50
Proceeds from Private Placement Warrants | $			$ 9,400,000
Class A Common Stock
Subsidiary or Equity Method Investee [Line Items]
Number of warrant holder to purchase share | shares			1
Initial Public Offering
Subsidiary or Equity Method Investee [Line Items]
Shares issued | shares		34,500,000	34,500,000
Shares issued, price per share		$ 10	$ 10
Initial Public Offering | Class A Common Stock
Subsidiary or Equity Method Investee [Line Items]
Purchase price of warrants			$ 11.50
Over-allotments
Subsidiary or Equity Method Investee [Line Items]
Shares issued | shares		4,500,000	4,500,000
Private Placement Warrants
Subsidiary or Equity Method Investee [Line Items]
Purchase price of warrants			$ 1.50
Number of private sales | Private			2
Number of warrants | shares			6,266,667
Proceeds from Private Placement Warrants | $			$ 9,400,000
Private Placement Warrants | Class A Common Stock
Subsidiary or Equity Method Investee [Line Items]
Shares issued | shares	7,500,000
Shares issued, price per share	$ 10

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details)	Feb. 11, 2021USD ($)	Jan. 26, 2021USD ($)shares	Dec. 23, 2020shares	Dec. 08, 2020USD ($)shares	Jan. 31, 2021shares	Sep. 30, 2021USD ($)$ / sharesshares	Sep. 30, 2021USD ($)$ / sharesshares	Jul. 30, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)shares
Related Party Transaction [Line Items]
Gross proceeds of shares issued	$ 345,000,000
Aggregate founder shares forfeited | shares							1,125,000
Sale price of common stock per share | $ / shares						$ 12	$ 12
Sale of common stock per share trading days							20 days
Trading day period							30 days
Initial business combination period							150 days
Liability related to conversion option						$ 0	$ 0
Energy Capital Partners Management L P | Maximum
Related Party Transaction [Line Items]
Related party transaction, agreed loan amount		$ 300,000
Administrative Services Agreement
Related Party Transaction [Line Items]
Payment made to an affiliate of sponsor							10,000
Expenses related to administrative support services						30,000	77,143
Expenses related to administrative support services included in accounts payable						10,000	10,000		$ 0
Unsecured Promissory Note
Related Party Transaction [Line Items]
Principal amount								$ 1,500,000
Note convertible price | $ / shares								$ 1.50
Debt instrument loan amount						$ 399,702	$ 399,702
Class B Common Stock
Related Party Transaction [Line Items]
Reverse stock split, description							6-for-5 reverse stock split
Common stock, shares outstanding | shares						8,625,000	8,625,000		8,625,000
Stock split ratio			0.833
Class B Common Stock | Tracy McKibben
Related Party Transaction [Line Items]
Number of shares transferred to founder by sponsor | shares					35,000
Class B Common Stock | Kathryn E. Coffey
Related Party Transaction [Line Items]
Number of shares transferred to founder by sponsor | shares					35,000
Class B Common Stock | Richard Burke
Related Party Transaction [Line Items]
Number of shares transferred to founder by sponsor | shares					35,000
Class B Common Stock | David Lockwood
Related Party Transaction [Line Items]
Number of shares transferred to founder by sponsor | shares					35,000
Class B Common Stock | Founder Shares
Related Party Transaction [Line Items]
Gross proceeds of shares issued				$ 25,000
Shares issued | shares				8,625,000
Reverse stock split, description							6-for-5 reverse stock split
Common stock, shares outstanding | shares		8,625,000	7,187,500
Stock split ratio		0.833

Commitments & Contingencies - A

Commitments & Contingencies - Additional Information (Details) - USD ($)	Feb. 11, 2021	Jan. 24, 2021	Sep. 30, 2021	Jul. 18, 2021
Commitments And Contingencies [Line Items]
Percentage of payments holders entitled			2.00%
Registration default percentage per month			2.00%
Purchase price of warrants			$ 11.50
Offering costs related to fair value instrument of founder shares transferred to sponsor			$ 1,249,759
Forward Purchase Agreement | Goldman Sachs Asset Management, L.P.
Commitments And Contingencies [Line Items]
Number of units issuable under forward purchase agreement		5,000,000
Number of shares consist of forward purchase unit		1
Number of warrants consist in one warrants of forward purchase unit		0.25
Forward purchase units issuable price per share		$ 10
Forward purchase units aggregate maximum amount issuable		$ 50,000,000
Number of warrant holder to purchase share		1
Purchase price of warrants		$ 11.50
Number of shares transferred to founder by sponsor	345,000
Offering costs related to fair value instrument of founder shares transferred to sponsor	$ 1,250,000
Reduction of temporary equity, founder shares transferred to sponsor			$ 1,200,000
Number of shares forfeit and return to sponsor by founder	172,500
Number of shares forfeit and return to sponsor by founder based on sponsor owned number of shares less than number of public shares purchased at closing of initial public offering	172,500
Forward Purchase Agreement | Minimum | Goldman Sachs Asset Management, L.P.
Commitments And Contingencies [Line Items]
Number of units issuable under forward purchase agreement	2,500,000
Side Letter | Forward Purchase Agreement | Goldman Sachs Asset Management, L.P.
Commitments And Contingencies [Line Items]
Number of units issuable under forward purchase agreement				2,500,000
Forward purchase units issuable price per share				$ 10
Forward purchase units aggregate amount issuable				$ 25,000,000
Over-allotments
Commitments And Contingencies [Line Items]
Additional units purchased on pro rata basis			4,500,000
Shares issued	4,500,000		4,500,000
Deferred fee per unit	$ 0.35
Deferred fee amount	$ 12,075,000

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Details)	9 Months Ended
	Sep. 30, 2021$ / sharesshares
Class Of Warrant Or Right [Line Items]
Number of fractional shares issued upon exercise of public warrant | shares	0
Warrants exercisable period after completion of business combination	30 days
Warrants exercisable period from closing of initial public offering	12 months
Maximum number of business days after closing of initial business combination to file with SEC and have an effective registration statement.	20 days
Purchase price of warrants	$ 11.50
Warrant expiration period after completion of business combination or earlier upon redemption or liquidation	5 years
Warrants will not be transferable, assignable or saleable, number of days after completion of business combination	30 days
Class A Common Stock
Class Of Warrant Or Right [Line Items]
Maximum effective issue price to closing of business combination	$ 9.20
Minimum percentage of total equity proceeds from issuances	60.00%
Number of trading days period starting on trading day prior to date on which company consummates initial business combination	20 days
Percentage of exercise price of warrants adjusted equal to higher of market value and newly issued price	115.00%
Number of trading days ending on third trading day prior to date on which notice of redemption sent to holders of warrants	10 days
Class A Common Stock | Redemption of Warrants When Price Per Share Equals or Exceeds 18
Class Of Warrant Or Right [Line Items]
Percentage of exercise price of warrants adjusted equal to higher of market value and newly issued price	180.00%
Redemption of warrants price per share	$ 18
Redemption price per warrant	$ 0.01
Minimum period of prior written notice of redemption of warrants	30 days
Minimum price per share required for redemption of warrants	$ 18
Warrants redemption covenant, threshold trading days	20 days
Warrants redemption covenant threshold consecutive trading days	30 days
Period of availability of current prospectus throughout redemption	30 days
Class A Common Stock | Redemption of Warrants When Price Per Share Equals or Exceeds 10
Class Of Warrant Or Right [Line Items]
Redemption of warrants price per share	$ 10
Minimum period of prior written notice of redemption of warrants	30 days
Adjusted last reported sale price per share on trading day	$ 10

Stockholders' Deficit - Additio

Stockholders' Deficit - Additional Information (Details)	Jan. 26, 2021shares	Dec. 23, 2020shares	Sep. 30, 2021$ / sharesshares	Jun. 30, 2021$ / shares	Mar. 31, 2021$ / shares	Feb. 11, 2021$ / shares	Dec. 31, 2020$ / sharesshares
Class Of Stock [Line Items]
Preferred stock, shares authorized			1,000,000				1,000,000
Preferred stock, par value | $ / shares			$ 0.0001				$ 0.0001
Preferred stock, shares issued			0				0
Preferred stock, shares outstanding			0				0
Class A Common Stock
Class Of Stock [Line Items]
Common stock, shares authorized			100,000,000				100,000,000
Common stock, par value | $ / shares			$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, voting rights			one vote for each share
Common stock, shares issued subject to possible redemption			34,500,000
Common stock, shares outstanding subject to possible redemption			34,500,000
Common stock, shares outstanding			0				0
Common stock, shares issued			0				0
Class B Common Stock
Class Of Stock [Line Items]
Common stock, shares authorized			10,000,000				10,000,000
Common stock, par value | $ / shares			$ 0.0001				$ 0.0001
Common stock, voting rights			each share of common stock entitling the holder to one vote
Reverse stock split, description			6-for-5 reverse stock split
Stock split ratio		0.833
Common stock, shares outstanding			8,625,000				8,625,000
Common stock, shares issued			8,625,000				8,625,000
Common stock, conversion of shares			one-for-one basis
Percentage of shares outstanding upon conversion			20.00%
Class B Common Stock | Founder Shares
Class Of Stock [Line Items]
Reverse stock split, description			6-for-5 reverse stock split
Stock split ratio	0.833
Common stock, shares outstanding	8,625,000	7,187,500
Stock split ratio, description			5-for-6 split

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details)	Sep. 30, 2021USD ($)
Level 1 | Money Market Funds | Marketable Securities
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investment, Fair Value	$ 345,026,384

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on Recurring Basis (Details)	Sep. 30, 2021USD ($)
Derivative liabilities:
Total Derivative liabilities	$ 12,412,430
Public Warrants
Derivative liabilities:
Total Derivative liabilities	7,131,150
Private Placement Warrants
Derivative liabilities:
Total Derivative liabilities	5,181,280
Forward Purchase Agreement
Derivative liabilities:
Total Derivative liabilities	100,000
Level 1
Derivative liabilities:
Total Derivative liabilities	7,131,150
Level 1 | Public Warrants
Derivative liabilities:
Total Derivative liabilities	7,131,150
Level 2
Derivative liabilities:
Total Derivative liabilities	5,181,280
Level 2 | Private Placement Warrants
Derivative liabilities:
Total Derivative liabilities	5,181,280
Level 3
Derivative liabilities:
Total Derivative liabilities	100,000
Level 3 | Forward Purchase Agreement
Derivative liabilities:
Total Derivative liabilities	$ 100,000

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2021USD ($)$ / shares	Sep. 30, 2021$ / shares
Fair Value Disclosures [Abstract]
Public warrants threshold waiting period		52 days
Forward purchase agreement purchase price upon business combination | $ / shares	$ 10	$ 10
Fair value transfers between Levels 1, 2 and 3 | $	$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Changes in Fair Value of Derivative Liabilities (Details) - Warrants - USD ($)	2 Months Ended	3 Months Ended
	Mar. 31, 2021	Sep. 30, 2021	Jun. 30, 2021
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liability, Beginning balance	$ 23,747,676	$ 22,597,083	$ 14,692,363
Recognized gain loss on change in fair value	9,055,313	10,184,653	(7,904,720)
Fair value of liability, Ending balance	14,692,363	12,412,430	22,597,083
Public Warrants
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liability, Beginning balance	12,880,575	12,075,000	7,927,238
Recognized gain loss on change in fair value	4,953,337	4,943,850	(4,147,762)
Fair value of liability, Ending balance	7,927,238	7,131,150	12,075,000
Private Placement Warrants
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liability, Beginning balance	9,358,640	8,773,333	5,759,693
Recognized gain loss on change in fair value	3,598,947	3,592,053	(3,013,640)
Fair value of liability, Ending balance	5,759,693	5,181,280	8,773,333
Forward Purchase Agreement
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liability, Beginning balance	1,508,461	1,748,750	1,005,432
Recognized gain loss on change in fair value	503,029	1,648,750	(743,318)
Fair value of liability, Ending balance	$ 1,005,432	$ 100,000	$ 1,748,750